Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue
US8871706B2 · kind B2 · utility
3Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 7, 2008 |
| Grant date | Oct 28, 2014 |
| Priority date | — |
| Expiry date | Aug 14, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of ameliorating inflammation, inhibiting proinflammatory cytokine and/or chemokine expression and treating various diseases and/or conditions incidental to the onset of inflammation, in a subject in need of treatment for such conditions, by administering select analogous of native hGhrelin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.